JP2017516785A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017516785A5 JP2017516785A5 JP2016569636A JP2016569636A JP2017516785A5 JP 2017516785 A5 JP2017516785 A5 JP 2017516785A5 JP 2016569636 A JP2016569636 A JP 2016569636A JP 2016569636 A JP2016569636 A JP 2016569636A JP 2017516785 A5 JP2017516785 A5 JP 2017516785A5
- Authority
- JP
- Japan
- Prior art keywords
- disease
- cancer
- salt according
- autoimmune
- carcinoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2596/CHE/2014 | 2014-05-27 | ||
| IN2596CH2014 | 2014-05-27 | ||
| IN2597CH2014 | 2014-05-27 | ||
| IN2597/CHE/2014 | 2014-05-27 | ||
| PCT/IB2015/053940 WO2015181728A1 (en) | 2014-05-27 | 2015-05-26 | Improved forms of a pi3k delta selective inhibitor for use in pharmaceutical formulations |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020088147A Division JP2020122022A (ja) | 2014-05-27 | 2020-05-20 | 医薬製剤用ｐｉ３ｋデルタ選択的抑制剤の改良形態 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017516785A JP2017516785A (ja) | 2017-06-22 |
| JP2017516785A5 true JP2017516785A5 (OSRAM) | 2017-08-03 |
| JP6987501B2 JP6987501B2 (ja) | 2022-01-05 |
Family
ID=53499042
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016569636A Expired - Fee Related JP6987501B2 (ja) | 2014-05-27 | 2015-05-26 | 医薬製剤用ｐｉ３ｋデルタ選択的抑制剤の改良形態 |
| JP2020088147A Pending JP2020122022A (ja) | 2014-05-27 | 2020-05-20 | 医薬製剤用ｐｉ３ｋデルタ選択的抑制剤の改良形態 |
| JP2022062937A Pending JP2022082680A (ja) | 2014-05-27 | 2022-04-05 | 医薬製剤用ｐｉ３ｋデルタ選択的抑制剤の改良形態 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020088147A Pending JP2020122022A (ja) | 2014-05-27 | 2020-05-20 | 医薬製剤用ｐｉ３ｋデルタ選択的抑制剤の改良形態 |
| JP2022062937A Pending JP2022082680A (ja) | 2014-05-27 | 2022-04-05 | 医薬製剤用ｐｉ３ｋデルタ選択的抑制剤の改良形態 |
Country Status (22)
| Country | Link |
|---|---|
| US (4) | US9969740B2 (OSRAM) |
| EP (2) | EP3149000B1 (OSRAM) |
| JP (3) | JP6987501B2 (OSRAM) |
| KR (1) | KR20170007480A (OSRAM) |
| CN (2) | CN106661030B (OSRAM) |
| AU (1) | AU2015265542B2 (OSRAM) |
| BR (1) | BR112016027674A2 (OSRAM) |
| CA (1) | CA2949932C (OSRAM) |
| CY (1) | CY1124316T1 (OSRAM) |
| DK (1) | DK3149000T3 (OSRAM) |
| EA (1) | EA032506B1 (OSRAM) |
| ES (1) | ES2880999T3 (OSRAM) |
| HR (1) | HRP20211151T1 (OSRAM) |
| HU (1) | HUE054916T2 (OSRAM) |
| IL (1) | IL249058B2 (OSRAM) |
| LT (1) | LT3149000T (OSRAM) |
| PL (1) | PL3149000T3 (OSRAM) |
| PT (1) | PT3149000T (OSRAM) |
| RS (1) | RS62136B1 (OSRAM) |
| SI (1) | SI3149000T1 (OSRAM) |
| SM (1) | SMT202100532T1 (OSRAM) |
| WO (1) | WO2015181728A1 (OSRAM) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SMT202100532T1 (it) * | 2014-05-27 | 2021-11-12 | Rhizen Pharmaceuticals S A | Sale tosilato cristallino di un inibitore 5 selettivo di pi3k delta per l’uso in formulazioni farmaceutiche |
| AU2017268839A1 (en) | 2016-05-27 | 2018-11-29 | Laboratoire Francais Du Fractionnement Et Des Biotechnologies | Combination of anti-CD20 antibody, P13 kinase-delta selective inhibitor, and BTK inhibitor to treat B-cell proliferative disorders |
| US20190247399A1 (en) | 2016-09-09 | 2019-08-15 | Tg Therapeutics, Inc. | Combination of an anti-cd20 antibody, pi3 kinase-delta inhibitor, and anti-pd-1 or anti-pd-l1 antibody for treating hematological cancers |
| WO2021009509A1 (en) | 2019-07-15 | 2021-01-21 | Johnson Matthey Public Limited Company | Amorphous umbralisib monotosylate |
| US20220143026A1 (en) | 2020-11-12 | 2022-05-12 | Tg Therapeutics, Inc. | Triple combination to treat b-cell malignancies |
| US11965032B1 (en) | 2022-06-01 | 2024-04-23 | Tg Therapeutics, Inc. | Anti-CD20 antibody compositions |
| US11814439B1 (en) | 2022-06-01 | 2023-11-14 | Tg Therapeutics, Inc. | Anti-CD20 antibody compositions |
| US11884740B1 (en) | 2022-06-01 | 2024-01-30 | Tg Therapeutics, Inc. | Anti-CD20 antibody compositions |
| US11807689B1 (en) | 2022-06-01 | 2023-11-07 | Tg Therapeutics, Inc. | Anti-CD20 antibody compositions |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100785363B1 (ko) * | 2000-04-25 | 2007-12-18 | 이코스 코포레이션 | 인간 포스파티딜-이노시톨 3-키나제 델타의 억제제 |
| PT1572744E (pt) | 2002-12-16 | 2010-09-07 | Genentech Inc | Variantes de imunoglobulina e utilizações destas |
| WO2005016348A1 (en) | 2003-08-14 | 2005-02-24 | Icos Corporation | Method of inhibiting immune responses stimulated by an endogenous factor |
| JP5794919B2 (ja) | 2008-11-13 | 2015-10-14 | ギリアード カリストガ エルエルシー | 血液学的な悪性疾患のための療法 |
| BRPI1012333A2 (pt) | 2009-03-24 | 2016-03-29 | Gilead Calistoga Llc | atropisômeros de derivados de 2-purinil-3-tolil-quinazolinonas e métodos de uso |
| SG175259A1 (en) | 2009-04-20 | 2011-11-28 | Gilead Calistoga Llc | Methods of treatment for solid tumors |
| LT2870157T (lt) | 2012-07-04 | 2017-12-11 | Rhizen Pharmaceuticals S.A. | Selektyvieji pi3k delta inhibitoriai |
| SMT202100532T1 (it) * | 2014-05-27 | 2021-11-12 | Rhizen Pharmaceuticals S A | Sale tosilato cristallino di un inibitore 5 selettivo di pi3k delta per l’uso in formulazioni farmaceutiche |
-
2015
- 2015-05-26 SM SM20210532T patent/SMT202100532T1/it unknown
- 2015-05-26 HR HRP20211151TT patent/HRP20211151T1/hr unknown
- 2015-05-26 US US15/313,454 patent/US9969740B2/en active Active
- 2015-05-26 LT LTEPPCT/IB2015/053940T patent/LT3149000T/lt unknown
- 2015-05-26 CN CN201580034288.7A patent/CN106661030B/zh not_active Expired - Fee Related
- 2015-05-26 PL PL15733532T patent/PL3149000T3/pl unknown
- 2015-05-26 HU HUE15733532A patent/HUE054916T2/hu unknown
- 2015-05-26 ES ES15733532T patent/ES2880999T3/es active Active
- 2015-05-26 PT PT157335324T patent/PT3149000T/pt unknown
- 2015-05-26 KR KR1020167036318A patent/KR20170007480A/ko not_active Ceased
- 2015-05-26 DK DK15733532.4T patent/DK3149000T3/da active
- 2015-05-26 AU AU2015265542A patent/AU2015265542B2/en not_active Ceased
- 2015-05-26 EP EP15733532.4A patent/EP3149000B1/en active Active
- 2015-05-26 JP JP2016569636A patent/JP6987501B2/ja not_active Expired - Fee Related
- 2015-05-26 CN CN202010471226.5A patent/CN111635406A/zh active Pending
- 2015-05-26 RS RS20210920A patent/RS62136B1/sr unknown
- 2015-05-26 BR BR112016027674A patent/BR112016027674A2/pt not_active Application Discontinuation
- 2015-05-26 CA CA2949932A patent/CA2949932C/en active Active
- 2015-05-26 WO PCT/IB2015/053940 patent/WO2015181728A1/en not_active Ceased
- 2015-05-26 SI SI201531656T patent/SI3149000T1/sl unknown
- 2015-05-26 EP EP21182208.5A patent/EP3971188A1/en not_active Withdrawn
- 2015-05-26 EA EA201692255A patent/EA032506B1/ru unknown
-
2016
- 2016-11-20 IL IL249058A patent/IL249058B2/en unknown
-
2018
- 2018-04-11 US US15/950,606 patent/US10414773B2/en active Active
-
2019
- 2019-08-30 US US16/557,091 patent/US10947244B2/en not_active Expired - Fee Related
-
2020
- 2020-05-20 JP JP2020088147A patent/JP2020122022A/ja active Pending
- 2020-12-23 US US17/247,806 patent/US20210269446A1/en not_active Abandoned
-
2021
- 2021-07-21 CY CY20211100652T patent/CY1124316T1/el unknown
-
2022
- 2022-04-05 JP JP2022062937A patent/JP2022082680A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017516785A5 (OSRAM) | ||
| JP2019163290A5 (OSRAM) | ||
| JP7749642B2 (ja) | Ｒｅｔｒｏｖｉｒｉｄａｅウイルス感染の処置において有用な治療用化合物を調製するための方法および中間体 | |
| HRP20171610T1 (hr) | Selektivni inhibitori pi3k delta | |
| JP2020537657A5 (OSRAM) | ||
| JP2017505808A5 (OSRAM) | ||
| HRP20211151T1 (hr) | Kristalinska tosilatna sol pi3k delta selektivnog inhibitora za uporabu u farmaceutskim formulacijama | |
| JP2017501234A5 (OSRAM) | ||
| JP2018511634A5 (OSRAM) | ||
| JP2022520236A (ja) | 化合物、組成物、及び、方法 | |
| JP2019518071A5 (OSRAM) | ||
| JP2019515952A5 (OSRAM) | ||
| JP2013525433A5 (OSRAM) | ||
| JP2020519654A5 (OSRAM) | ||
| JP2016128501A5 (OSRAM) | ||
| JP2016537346A5 (OSRAM) | ||
| ES2588170T3 (es) | 5-[(3,3,3-Trifluoro-2-hidroxi-1-arilpropil)amino]-1H-quinolin-2-onas, procedimiento para su producción y su uso como agentes antiinflamatorios | |
| JP2020066629A5 (OSRAM) | ||
| JP2013502396A5 (OSRAM) | ||
| TW201609679A (zh) | 磷脂酸肌醇-3-激酶抑制劑的製造方法 | |
| CN119110801A (zh) | 选择性抑制parp1的氟代喹喔啉酮衍生物 | |
| JP2010529986A5 (OSRAM) | ||
| JP2025505112A (ja) | ベンゾピリミジン化合物及びその使用 | |
| JP2013525448A5 (OSRAM) | ||
| JP2013515737A5 (OSRAM) |